Search Results 1651-1660 of 18452 for Immunode

1. Phase 2a Open-Label Pilot Study Of VTX2735 In Recurrent Pericarditis - Mayo Clinic

   History of clinically significant immunosuppressive disorder, autoimmune/autoinflammatory disorder, primary or secondary immunodeficiency, or disorder with ...

2. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

   Known uncontrolled human immunodeficiency virus (HIV) infection. Severe bacterial, fungal, viral, and/or parasitic infections under treatment with ...

3. Olaparib or Cediranib Maleate and Olaparib Compared With Standard Platinum-Based Chemotherapy in Treating Patients With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - Mayo Clinic

   Known human immunodeficiency virus (HIV)-positive individuals are ineligible; Patients may not use any complementary or alternative medicines including ...

4. A Study To Test The Addition Of The Drug Cabozantinib To Chemotherapy In Patients With Newly Diagnosed Osteosarcoma - Mayo Clinic

   Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible as long ...

5. Dendritic Cell Therapy, Cryosurgery, and Pembrolizumab in Treating Patients With Non-Hodgkin Lymphoma - Mayo Clinic

   Negative human immunodeficiency virus (HIV), hepatitis B and C, and tuberculosis (TB) test. Provide written informed consent. Willing to return to the ...

6. A Study to Evaluate the Safety and Effectiveness of Tildacerfont to Reduce Glucocorticoid Use in Classic Congenital Adrenal Hyperplasia - Mayo Clinic

   Active hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) at screening. Had or has a clinically significant psychiatric disorder, including the ...

7. Filgotinib In The Induction And Maintenance Of Remission In Adults With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

   History of opportunistic infection or immunodeficiency syndrome. Currently on any chronic systemic (oral or intravenous) anti-infective therapy for chronic ...

8. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

   Patients who are human immunodeficiency virus (HIV)-positive are eligible if: CD4+ cell count greater or equal to 250 cells/mm^3; If patient is on ...

9. Valganciclovir (oral route) - Mayo Clinic

   Valganciclovir is used to treat symptoms of cytomegalovirus (CMV) retinitis, an infection in the eyes of people with acquired immunodeficiency syndrome (AIDS).

10. A Study to Evaluate Pemetrexed and Pembrolizumab to Treat Recurrent and/or Metastatic Salivary Gland Malignancies - Mayo Clinic

    Known active human immunodeficiency virus (HIV) infection (defined as patients who are not on anti-retroviral treatment and have detectable viral load and CD4+ ...